HU9502431D0 - Adhesionsrezeptor antagonists - Google Patents

Adhesionsrezeptor antagonists

Info

Publication number
HU9502431D0
HU9502431D0 HU9502431A HU9502431A HU9502431D0 HU 9502431 D0 HU9502431 D0 HU 9502431D0 HU 9502431 A HU9502431 A HU 9502431A HU 9502431 A HU9502431 A HU 9502431A HU 9502431 D0 HU9502431 D0 HU 9502431D0
Authority
HU
Hungary
Prior art keywords
adhesionsrezeptor
antagonists
ala
phenyl
formula
Prior art date
Application number
HU9502431A
Other languages
English (en)
Other versions
HUT76790A (en
HU223844B1 (hu
Inventor
Sabine Bernotat-Danielowski
Joachim Gante
Horst Juraszyk
Guido Melzer
Hanns Wurziger
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HU9502431D0 publication Critical patent/HU9502431D0/hu
Publication of HUT76790A publication Critical patent/HUT76790A/hu
Publication of HU223844B1 publication Critical patent/HU223844B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
HU9502431A 1994-08-19 1995-08-17 2-Oxazolidinon-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények HU223844B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4429461A DE4429461A1 (de) 1994-08-19 1994-08-19 Adhäsionsrezeptor-Antagonisten

Publications (3)

Publication Number Publication Date
HU9502431D0 true HU9502431D0 (en) 1996-05-28
HUT76790A HUT76790A (en) 1997-11-28
HU223844B1 HU223844B1 (hu) 2005-02-28

Family

ID=6526098

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9502431A HU223844B1 (hu) 1994-08-19 1995-08-17 2-Oxazolidinon-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények

Country Status (21)

Country Link
US (1) US5614535A (hu)
EP (1) EP0697408B1 (hu)
JP (1) JP3810833B2 (hu)
KR (1) KR100365870B1 (hu)
CN (1) CN1204889C (hu)
AT (1) ATE212339T1 (hu)
AU (1) AU698412B2 (hu)
CA (1) CA2156360C (hu)
CZ (1) CZ290984B6 (hu)
DE (2) DE4429461A1 (hu)
DK (1) DK0697408T3 (hu)
ES (1) ES2170114T3 (hu)
HU (1) HU223844B1 (hu)
NO (1) NO305206B1 (hu)
PL (1) PL182615B1 (hu)
PT (1) PT697408E (hu)
RU (1) RU2156765C2 (hu)
SK (1) SK281754B6 (hu)
TW (1) TW425392B (hu)
UA (1) UA35607C2 (hu)
ZA (1) ZA956929B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
US7049140B1 (en) * 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
DE19958153A1 (de) * 1999-12-03 2001-06-07 Yamanouchi Pharma Co Ltd Oxazolidinon-Derivate
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7306925B2 (en) * 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2004069832A2 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
BRPI0413838A (pt) * 2003-08-25 2006-10-24 Warner Lambert Co compostos de ariloxazolidinona antimicrobianos
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
KR101224368B1 (ko) 2004-06-04 2013-01-22 더 스크립스 리서치 인스티튜트 혈관신생 질환 치료용 조성물 및 방법
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437388A (en) * 1948-03-09 Z-oxazolidone compounds and proc
FR2068423A1 (en) * 1969-11-06 1971-08-27 Delalande Sa 3-phenyl-5-ethoxycarbonyl-2-oxazolidinones antiarrhythmics
US4866182A (en) * 1988-02-18 1989-09-12 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoyl and aroyl oxazolones
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
EP0417044A3 (en) * 1989-09-07 1991-06-12 Ciba-Geigy Ag Oxazolidinones and thiones as plantgrowth regulators
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
US5298516A (en) * 1991-03-27 1994-03-29 Sankyo Company, Limited Thiazolidone compounds and method of using the same as a vasodilator
DE4405633A1 (de) * 1993-05-01 1994-11-03 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III

Also Published As

Publication number Publication date
NO953253L (no) 1996-02-20
EP0697408B1 (de) 2002-01-23
HUT76790A (en) 1997-11-28
RU2156765C2 (ru) 2000-09-27
NO305206B1 (no) 1999-04-19
CN1125575A (zh) 1996-07-03
CA2156360C (en) 2011-01-11
DE4429461A1 (de) 1996-02-22
SK100195A3 (en) 1996-06-05
CZ208795A3 (en) 1996-06-12
SK281754B6 (sk) 2001-07-10
AU2852295A (en) 1996-02-29
PL310070A1 (en) 1996-03-04
KR100365870B1 (ko) 2003-03-04
PT697408E (pt) 2002-07-31
US5614535A (en) 1997-03-25
EP0697408A1 (de) 1996-02-21
DE59510010D1 (de) 2002-03-14
ZA956929B (en) 1996-03-29
CA2156360A1 (en) 1996-02-20
TW425392B (en) 2001-03-11
NO953253D0 (no) 1995-08-18
HU223844B1 (hu) 2005-02-28
PL182615B1 (pl) 2002-02-28
DK0697408T3 (da) 2002-04-15
CZ290984B6 (cs) 2002-11-13
AU698412B2 (en) 1998-10-29
CN1204889C (zh) 2005-06-08
ATE212339T1 (de) 2002-02-15
UA35607C2 (uk) 2001-04-16
KR960007586A (ko) 1996-03-22
ES2170114T3 (es) 2002-08-01
JPH0892227A (ja) 1996-04-09
JP3810833B2 (ja) 2006-08-16

Similar Documents

Publication Publication Date Title
HU9502431D0 (en) Adhesionsrezeptor antagonists
EP0578083A3 (hu)
HUT74013A (en) Polyene compounds, pharmaceutical and cosmetical compositions containing them, and use of them
EP0291234A3 (en) Peptidic human leukocyte elastase (hle) inhibitors
SG52326A1 (en) 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
PT807633E (pt) Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6)
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
WO1998046576A3 (en) Halo-alkoxycarbonyl prodrugs
HU9501167D0 (en) New bicyclic aromatic compounds, pharmaceutical and cosmetical compositions containing them, and use of them
PT722319E (pt) Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
ES2129123T3 (es) Nuevo derivado de bisoxadiazolidina.
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
PL323339A1 (en) Novel benzopyranic compounds, method of obtaining them and pharmaceutic compositions containing such compounds
BG103329A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
IL120863A0 (en) Sulfur-containing heterocyclic bradykinin antagonists process for their preparation and their use
IL116601A (en) 4, 5, 6, 7-tetrahydro- 2-saccharinylmethyl phosphates, phsophonates and phosphinates and pharmaceutical compositions containing them
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP9902678A2 (hu) Protein kináz-C inhibitor hatású, halogénatommal szubsztituált bisz(indol)-maleinmid-származékok, valamint ezeket tartalmazó gyógyászati készítmények
EA199900688A1 (ru) Хиноксалиндионы
DK0870759T3 (da) Aminerede 6,7,8,9-tetrahydrocyclopenta[a]naphthalen- og 2,3-dihydrocyclopenta[e]inden-derivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende sådanne derivater
ATE205189T1 (de) Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
PT90831A (pt) Processo para a preparacao de eteres da 2-amino-7-hidroxitetralina

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050105

MM4A Lapse of definitive patent protection due to non-payment of fees